A carregar...
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...
Na minha lista:
| Publicado no: | BMJ Open Diabetes Res Care |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039592/ https://ncbi.nlm.nih.gov/pubmed/31958305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000833 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|